Evaluation of medicinal products for the treatment of irritable bowel syndrome - Scientific guideline

This document addresses the European Union regulatory position in the main topics of clinical development of new medicinal products in the treatment of irritable bowel syndrome.

Keywords: Irritable bowel syndrome, Rome criteria, patient reported outcome (PRO), health related quality of life (HrQoL)

Document history


How useful was this page?

Add your rating
1 rating